Open AccessOptical Coherence Tomography Angiography Biomarkers Predict Anatomical Response to Bevacizumab in Diabetic Macular Edema
Author(s) -
Ayman G. Elnahry,
A. Mohammad Noureldine,
Ahmed Abdelkader,
Osama Sorour,
David J. Ramsey
Publication year - 2022
Publication title -
diabetes, metabolic syndrome and obesity
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.853
H-Index - 43
ISSN - 1178-7007
DOI - 10.2147/dmso.s351618
Subject(s) - medicine , optical coherence tomography , bevacizumab , diabetic macular edema , optical coherence tomography angiography , ophthalmology , angiography , radiology , diabetic retinopathy , diabetes mellitus , chemotherapy , endocrinology
To identify biomarkers that may predict an early anatomical response to the treatment of diabetic macular edema (DME) with intravitreal bevacizumab (IVB) by means of optical coherence tomography angiography (OCTA).